Metabolic Features of Increased Gut Permeability, Inflammation, and Altered Energy Metabolism Distinguish Agricultural Workers at Risk for Mesoamerican Nephropathy

Metabolic Features of Increased Gut Permeability, Inflammation, and Altered Energy Metabolism Distinguish Agricultural Workers at Risk for Mesoamerican Nephropathy

Mesoamerican nephropathy (MeN) is a form of chronic kidney disease found predominantly in young men in Mesoamerica. Strenuous agricultural labor is a consistent risk factor for MeN, but the pathophysiologic mechanism leading to disease is poorly understood. We compared the urine metabolome among men...

Full description

Bibliographic Details
Main Authors:	Nathan H. Raines, Dominick A. Leone, Cristina O’Callaghan-Gordo, Oriana Ramirez-Rubio, Juan José Amador, Damaris Lopez Pilarte, Iris S. Delgado, Jessica H. Leibler, Nieves Embade, Rubén Gil-Redondo, Chiara Bruzzone, Maider Bizkarguenaga, Madeleine K. Scammell, Samir M. Parikh, Oscar Millet, Daniel R. Brooks, David J. Friedman
Format:	Article
Language:	English
Published:	MDPI AG 2023-02-01
Series:	Metabolites
Subjects:	Mesoamerican nephropathy (MeN) chronic kidney disease of unknown etiology (CKDu) chronic kidney disease of nontraditional cause (CKDnt) nicotinamide adenine dinucleotide (NAD+) kynurenate tryptophan
Online Access:	https://www.mdpi.com/2218-1989/13/3/325

Similar Items

Occupational risks associated with chronic kidney disease of non-traditional origin (CKDnt) in Brazil: it is time to dig deeper into a neglected problem
by: Rafael Junqueira Buralli, et al.
Published: (2024-04-01)

Editorial: Social determinants of kidney health: a global perspective
by: Guillermo Garcia-Garcia, et al.
Published: (2023-08-01)

Kidney disease characteristics, prevalence, and risk factors in León, Nicaragua: a population-based study
by: Anna Strasma, et al.
Published: (2023-11-01)

The unexpected diagnosis of karyomegalic interstitial nephritis in a presumed case of Mesoamerican Nephropathy: a case report
by: Lawrence Kwon, et al.
Published: (2025-03-01)

Decreasing incidence of hospital diagnosed CKD/CKDu in North Central Province of Sri Lanka: is it related to provision of drinking water reverse osmosis plants?
by: Asanga Venura Ranasinghe, et al.
Published: (2024-03-01)

Unraveling the nexus of NAD+ metabolism and diabetic kidney disease: insights from murine models and human data
by: Sisi Yang, et al.
Published: (2024-05-01)

Heavy metal association with chronic kidney disease of unknown cause in central India-results from a case-control study
by: Mahendra Atlani, et al.
Published: (2024-04-01)

Effects of Foods of Mesoamerican Origin in Adipose Tissue and Liver-Related Metabolism
by: Alejandra Meza-Rios, et al.
Published: (2023-10-01)

Progress in research on mechanism of nicotinamide adenine dinucleotide and its precursors against aging-related diseases
by: Shixiong ZHENG, et al.
Published: (2023-06-01)

NAD+ metabolism and therapeutic strategies in cardiovascular diseases
by: Chongxu Shi, et al.
Published: (2024-09-01)

Pathobiochemistry of Aging and Neurodegeneration: Deregulation of NAD+ Metabolism in Brain Cells
by: Nataliya A. Kolotyeva, et al.
Published: (2024-12-01)

The Effect of Metformin in Diabetic and Non-Diabetic Rats with Experimentally-Induced Chronic Kidney Disease
by: Mohammed Al Za’abi, et al.
Published: (2021-05-01)

Nicotinamide Adenine Dinucleotide (NAD) Metabolism as a Relevant Target in Cancer
by: Lola E. Navas, et al.
Published: (2022-08-01)

Acute kidney injury in rural workers: An environmental-stress nephropathy
by: Carlos G. Musso, et al.
Published: (2023-11-01)

Clinical Evidence for Targeting NAD Therapeutically
by: Dina Radenkovic, et al.
Published: (2020-09-01)

First Old WomanMan and the Mesoamerican Diphrastic Kenning of Engendering
by: David Freidel
Published: (2024-01-01)

Research progress on the role of NAD+ metabolism in cell function and related-diseases
by: HE Sheng-mei, ZHAO Hou-yu
Published: (2022-02-01)

Safety and efficacy of long-term nicotinamide mononucleotide supplementation on metabolism, sleep, and nicotinamide adenine dinucleotide biosynthesis in healthy, middle-aged Japanese men
by: Shintaro Yamaguchi, et al.
Published: (2024-02-01)

Evaluation of the zinc succinate toxic eﬀect on the cerebral cortex of rat
by: G. A. Piavchenko, et al.
Published: (2019-06-01)

Curcumin and its combination with a reduced dose of rosuvastatin: A promising therapy for chronic kidney disease and associated dyslipidemia in rat animal models
by: Dina Lagumdžija, et al.
Published: (2024-10-01)

Modulation of the thiol redox proteome by sugarcane ash-derived silica nanoparticles: insights into chronic kidney disease of unknown etiology
by: Arthur D. Stem, et al.
Published: (2025-02-01)

Tubulointerstitial nephropathy is the predominant finding in men in a review of more than 3000 renal biopsies over a 10-year period from Sri Lanka
by: Jennifer Pett, et al.
Published: (2024-09-01)

The Effect of a 7-Week Training Period on Changes in Skin NADH Fluorescence in Highly Trained Athletes
by: Olga Bugaj, et al.
Published: (2020-07-01)

Nicotinamide mononucleotide supplementation rescues mitochondrial and energy metabolism functions and ameliorates inflammatory states in the ovaries of aging mice
by: Jinghui Liang, et al.
Published: (2024-10-01)

Immune infiltration and prognosis in gastric cancer: role of NAD+ metabolism-related markers
by: Yu Xing, et al.
Published: (2024-07-01)

Causes of Chronic Kidney Disease of Non-Traditional Origin in Central America: An Approach Based on Medical Geology
by: Benedicto Valdés-Rodríguez, et al.
Published: (2023-11-01)

Chronic Kidney Disease of Unknown Etiology: A Global Health Threat in Rural Agricultural Communities—Prevalence, Suspected Causes, Mechanisms, and Prevention Strategies
by: Zineb Ben Khadda, et al.
Published: (2024-12-01)

Effects of Fenofibrate and Gemfibrozil on Kynurenic Acid Production in Rat Kidneys In Vitro: Old Drugs, New Properties
by: Izabela Zakrocka, et al.
Published: (2023-11-01)

Exploring the Therapeutic Potential of Nicotinamide Mononucleotide: A Review of Safety and Efficacy with Emphasis on Diabetes
by: Hubert Gugulski, et al.
Published: (2024-08-01)

Current knowledge about pyruvate supplementation: A brief review
by: Robert A. Olek, et al.
Published: (2024-12-01)

Urinary Biomarkers of Renal Injury KIM-1 and NGAL: Reference Intervals for Healthy Pediatric Population in Sri Lanka
by: P. Mangala C. S. De Silva, et al.
Published: (2021-08-01)

Metabolome evidence of CKDu risks after chronic exposure to simulated Sri Lanka drinking water in zebrafish
by: Pan-Pan Jia, et al.
Published: (2024-03-01)

Effect of Riociguat on Adenine-Induced Chronic Kidney Disease in Rats
by: Aly M. Abdelrahman, et al.
Published: (2025-02-01)

Comprehensive analysis of a NAD+ metabolism-derived gene signature to predict the prognosis and immune landscape in endometrial cancer
by: Dan Hu, et al.
Published: (2024-03-01)

Function of NAD metabolism in white adipose tissue: lessons from mouse models
by: So Young Kwon, et al.
Published: (2024-12-01)

Identification and validation of NAD+ metabolism-related biomarkers in patients with diabetic peripheral neuropathy
by: Chenhao Ye, et al.
Published: (2024-02-01)

Metals and Metallothionein Expression in Relation to Progression of Chronic Kidney Disease of Unknown Etiology (CKDu) in Sri Lanka
by: S. H. Nandana P. Gunawickrama, et al.
Published: (2022-06-01)

Decrease of NAD+ Inhibits the Apoptosis of OLP T Cells via Inducing Mitochondrial Fission
by: Zhang ZY, et al.
Published: (2025-01-01)

The effects of nicotinamide adenine dinucleotide in cardiovascular diseases: Molecular mechanisms, roles and therapeutic potential
by: Xiaokai Zhang, et al.
Published: (2022-07-01)

Nicotinamide adenine dinucleotide treatment confers resistance to neonatal ischemia and hypoxia: effects on neurobehavioral phenotypes
by: Xiaowen Xu, et al.
Published: (2024-01-01)